Try our Advanced Search for more refined results
Aurobindo Pharma Ltd.
-
Order | Filed: May 31, 2024 | Entered: May 31, 2024 Connecticut et al v. Sandoz, Inc. et al
Anti-Trust | Connecticut
Order
ORDER: The States have filed a "limited objection" to the Court's order, ECF No. 193, indicating that further developments since the briefing was completed regarding the defendants' motion to enforce the MDL Court's order have "largely moot[ed]" that motion. The Defendants shall file a response of not more than 3 pages by 3pm on June 4, 2024, and shall indicate in the response what portions of their motion they contend is not moot. Unless the Defendants' position is that their motion is now entirely moot, in which case they shall promptly so inform the States and shall so indicate in their response, the parties shall also make the other filings required by the last sentence of ECF No. 193 by 5pm on June 4, 2024.
Signed by Judge Michael P. Shea on 5/31/24. (Constantine, A.) -
Misc | Filed: May 31, 2024 | Entered: May 31, 2024 Merck KGaA et al v. Hopewell Pharma Ventures, Inc., et al.
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Redacted Document
REDACTED VERSION of 131 Letter,,, by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1(a), # 3 Exhibit 1(b), # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10(a), # 13 Exhibit 10(b), # 14 Exhibit 10(c), # 15 Exhibit 10(d), # 16 Exhibit 10(e), # 17 Exhibit 11, # 18 Exhibit 12, # 19 Exhibit 13, # 20 Exhibit 14, # 21 Exhibit 15, # 22 Exhibit 16)(Delcollo, Renee)
-
Misc | Filed: May 31, 2024 | Entered: May 31, 2024 INTRA-CELLULAR THERAPIES, INC. v. AUROBINDO PHARMA LTD. et al
Patent - Abbreviated New Drug Application(ANDA) | New Jersey
Letter
Letter from Dennies Varughese to the Honorable J. Brendan Day, U.S.M.J.. (Attachments: # 1 Text of Proposed Order and Stipulation)(VARUGHESE, DENNIES)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login